IKKα promotes lung adenocarcinoma growth through activation of ERK signaling via DARPP-32-mediated inhibition of PP1 activity
S. K. Alam, L. Wang, Z. Zhu, L. H. Hoeppner
bioRxiv · Jul 8, 2022 · PreprintCancer Biology
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
S. K. Alam, L. Wang, Z. Zhu, L. H. Hoeppner
bioRxiv · Jul 8, 2022 · PreprintCancer Biology
K. N. Phoenix, Z. Yue, L. Yue, C. G. Cronin, B. T. Liang, L. H. Hoeppner, K. P. Claffey
This study identifies PLCβ2 as a key regulator of VEGF-induced vascular permeability by modulating calcium flux and PIP2 levels, showing therapeutic potential for diseases involving vascular leakage.
bioRxiv · Mar 9, 2022Cell Biology
S. K. Alam, Y. Zhang, L. Wang, Z. Zhu, C. E. Hernandez, Y. Zhou, N. Yang, J. Lei, X. Chen, L. Zeng, M. A. Klein, L. H. Hoeppner
This study identifies DARPP-32 as a mediator of ERBB3-driven resistance to EGFR TKIs in lung adenocarcinoma, showing its role in promoting oncogenic signaling and tumor progression.
bioRxiv · Feb 12, 2021Cancer Biology
S. K. Alam, L. Wang, Y. Ren, C. E. Hernandez, F. Kosari, A. C. Roden, R. Yang, L. H. Hoeppner
The paper shows that ASCL1-regulated DARPP-32 and t-DARPP promote SCLC growth and survival through Akt/Erk signaling and anti-apoptotic pathways, with t-DARPP overexpression linked to Notch signaling activation in SCLC patients.
bioRxiv · Jul 16, 2019Cancer Biology
S. K. Alam, M. Astone, P. Liu, S. R. Hall, A. M. Coyle, E. N. Dankert, D. K. Hoffman, W. Zhang, R. Kuang, A. C. Roden, A. S. Mansfield, L. H. Hoeppner
The paper shows that DARPP-32 and t-DARPP promote lung cancer growth via IKKα-dependent migration and Akt/Erk-mediated survival, with t-DARPP linked to poor survival and higher tumor stages.
bioRxiv · Dec 6, 2017Cancer Biology